目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value

4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation

5 Market Outlook
5.1. Market value forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?

8 Company Profiles
8.1. Takeda Pharmaceutical Company Limited
8.2. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
8.3. Shanghai Kehua Bio-engineering Co Ltd
8.4. Astellas Pharma Inc.

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: Asia-Pacific biotechnology industry value: $ billion, 2016-21
Table 2: Asia-Pacific biotechnology industry category segmentation: % share, by value, 2016-2021
Table 3: Asia-Pacific biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: Asia-Pacific biotechnology industry geography segmentation: $ billion, 2021
Table 5: Asia-Pacific biotechnology industry value forecast: $ billion, 2021-26
Table 6: Takeda Pharmaceutical Company Limited: key facts
Table 7: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 8: Takeda Pharmaceutical Company Limited: Key Employees
Table 9: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 10: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: key facts
Table 11: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Annual Financial Ratios
Table 12: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Key Employees
Table 13: Shanghai Kehua Bio-engineering Co Ltd: key facts
Table 14: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
Table 15: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
Table 16: Astellas Pharma Inc.: key facts
Table 17: Astellas Pharma Inc.: Annual Financial Ratios
Table 18: Astellas Pharma Inc.: Key Employees
Table 19: Astellas Pharma Inc.: Key Employees Continued
Table 20: Asia-Pacific exchange rate, 2017-21

List of Figures
Figure 1: Asia-Pacific biotechnology industry value: $ billion, 2016-21
Figure 2: Asia-Pacific biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: Asia-Pacific biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: Asia-Pacific biotechnology industry value forecast: $ billion, 2021-26
Figure 5: Forces driving competition in the biotechnology industry in Asia-Pacific, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in Asia-Pacific, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in Asia-Pacific, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Asia-Pacific, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Asia-Pacific, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Asia-Pacific, 2021